Impact of a novel coronavirus infection experienced during pregnancy on perinatal outcomes
https://doi.org/10.52485/19986173_2023_3_118
Abstract
Since the beginning of the COVID-19 pandemic, there have been reports about the peculiarities of the course of a new coronavirus infection in a special group of patients - pregnant women. Physiological, immunological changes in the pregnant woman's body lead to the transformation of innate and adaptive immune responses from an inflammatory phenotype to an anti-inflammatory one, suppressing fetal immune rejection reactions and contributing to the passive transmission of maternal antibodies to the fetus. Currently, there is evidence of possible vertical transmission of a new coronavirus infection from mother to fetus and the impact of SARS-CoV2 on the fetus on the thrombogenic orientation of its hemostasis, with the development of adverse outcomes. Literature review and clinical case of an unfavorable perinatal outcome of a COVID-19 infection during pregnancy with the development of hemostasis disorder in a newborn are presented.
About the Authors
A. V. Ignatyeva
Chita State Medical Academy
Russian Federation
Russian Federation
39A Gorky str., Chita, 672000
V. V. Kocherova
Chita State Medical Academy
Russian Federation
Russian Federation
39A Gorky str., Chita, 672000
N. S. Soktoeva
Chita State Medical Academy
Russian Federation
Russian Federation
39A Gorky str., Chita, 672000
E. P. Bataeva
Chita State Medical Academy
Russian Federation
Russian Federation
39A Gorky str., Chita, 672000
References
1. Huang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020. 395. 497-506. Doi:10.1016/S0140-6736(20)30183-5.
2. Chen N., Zhou M., Dong X. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020. 395 (10223). 507-513. Doi:10.1016/S0140-6736(20)30211-72020.
3. Zhang Z.-J., Yu X.-J., Fu T., et al. Novel Coronavirus Infection in Newborn Babies Under 28 Days in China. European Respiratory Journal. 2020. 55(6)/ 2000697. Doi: 10.1183/13993003.00697-202.
4. Di Mascio D., Khalil A., Saccone G., et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol. MFM 2. 100107. 2020. 2(2).100107. Doi:10.1016/j.ajogmf.2020.100107.
5. Adamyan L.V., Vechorko V.I., Konysheva O.V., Harchenko E.I. Pregnancy and COVID-19: current issues (literature review). Problemy reprodukcii. 2021. 27(3). 70-77. Doi: 10.17116/repro20212703170. in Russian.
6. Bellanti J.A. The role of the allergist/immunologist in the COVID19 pandemic: A Janus-faced presentation. Allergy Asthma Proc. 2020. 41(6). 397-412. Doi: 10.2500/aap.2020.41.200072.
7. Belyakov N.A., Rassohin V.V., YAstrebova E.B. Coronavirus infection COVID-19. Nature of the virus, pathogenesis, clinical manifestations. VIC-infekcia i immunosupressii. 12(1). 2020. 7-21. Doi:10.22328/2077-9828-2020-12-1-7-21. in Russian.
8. Ignat'eva A.V., Cybikov N.N., Soktoeva N.S., Sibira O.F. Hemostasis in children born to mothers with COVID-19. Current problems of pathophysiology. Collection of scientific articles of the International Scientific and Practical Conference. Under the general editorship of N.V. Lareva. Chita, 2022. 87-89. in Russian.
9. Moderbacher C.R., Ramirez S.I., Don J.M. at el. Antigenspecific adaptive immunity to SARS-CoV2 in acute COVID-19 and association with age and disease severity. Cell. 2020. 183(4)/ 996-1012.e19. Doi: 10.1016/j.cell.2020.09.038.
10. Zhou P., Yang X., Wang X. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020. 579(7798). 270-273. Doi: 10.1038/s41586-020-2012-7.
11. Li C., Wu H., Yan H. et al. T cell responses to whole SARS coronavirus in humans. J. Immunol. 2008. 181(8). 5490-5500. Doi: 10.4049/jimmunol.181.8.5490.
12. Ivashkiv L., Donlin L. Regulation of type I interferon responses. Nature reviews Immunology. 2014. 14(1). 36-49. Doi: 10.1038/nri3581.
13. José Villar, MD; Shabina Ariff, MD; Robert B. Gunier, PhD; et al. Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 InfectionThe INTERCOVID Multinational Cohort Study JAMA Pediatr. 2021. 175(8). 817-826. doi: 10.1001/jamapediatrics.2021.1050.
14. Zaigham M., Holmberg A., Karlberg M.L., et al. Intrauterine vertical SARS-CoV-2 infection: a case confirming transplacental transmission followed by divergence of the viral genome. BJOG. 2021 Jul. 128(8).1388-1394. doi: 10111/1471-0528/16682.
15. Schwartz D.A., Morotti D. Placental pathology of COVID-19 with and without fetal and neonatal infection: Trophoblast necrosis and chronic histiocytic intervillositis as risk factors for transplacental transmission of SARS-CoV-2. Viruses. 2020. 12. 1308. doi: 10.3390/v12111308.
16. Schwartz D.A., Avvad-Portari E., Babál P., et al. Placental tissue destruction and insufficiency from COVID-19 causes stillbirth and neonatal death from hypoxic-ischemic injury: A study of 68 cases with SARS-CoV-2 placentitis from 12 countries. Arch. Pathol. Lab. Med. 2022 doi: 10.5858/arpa.2022-0029-SA.
17. Campi F., Longo D., Bersani I., et al. Neonatal Cerebral Venous Thrombosis following Maternal SARS-CoV-2 infection in Pregnancy Neonatology. 2022. 119(2). 268-272. doi: 10.1159/000520537.
18. Abdulaziz-Opiela G., Sobielaj A., Sibrecht G., et al. Prenatal and Neonatal Pulmonary Thrombosis as a Potential Complication of SARS-CoV-2 Infection in Late Pregnancy. Int J Mol Sc. 2023 Apr 21. 24(8). 7629. doi: 10.3390/ijms24087629.
Review
For citations:
Ignatyeva A.V., Kocherova V.V., Soktoeva N.S., Bataeva E.P. Impact of a novel coronavirus infection experienced during pregnancy on perinatal outcomes. Transbaikalian Medical Bulletin. 2023;(3):118-125. (In Russ.) https://doi.org/10.52485/19986173_2023_3_118
Views:
100
Email this article 